| 注册
首页|期刊导航|临床误诊误治|肝癌伴肝功能不全患者的介入治疗:策略与哲学思想

肝癌伴肝功能不全患者的介入治疗:策略与哲学思想

夏景林

临床误诊误治2018,Vol.31Issue(1):1-5,5.
临床误诊误治2018,Vol.31Issue(1):1-5,5.DOI:10.3969/j.issn.1002-3429.2018.01.001

肝癌伴肝功能不全患者的介入治疗:策略与哲学思想

Chemoembolization for Liver Cancer Patients with Decompensate Liver Function:Strategy and Philosophy

夏景林1

作者信息

  • 1. 200032 上海,复旦大学附属中山医院肝肿瘤内科 复旦大学肝癌研究所
  • 折叠

摘要

Abstract

Liver cancer with decompensated liver function is conventionally contraindication for chemoembolization. Liver dysfunction including jaundice, alanine aminotransferase elevation, hypoproteinemia with ascites, hypersplenism with leukocyte and/or thrombocytopenia. Based on long-term practice, this paper proposes the strategy of chemoembolization for liver cancer patients with decompensated liver function. Firstly, modify the chemoembolization method ( Dose-reduced chemo-embolization) ,which means reduce the dose of chemotherapeutic drugs and the dosage of embolic agent remains normal. Sec-ondly, differential the causes of liver dysfunction, such as obstructive jaundice caused by tumor compression and elevated ala-nine aminotransferase caused by tumor. For patient like these, chemoembolization should be the first choice, rather than re-duce the jaundice or protect the liver function. For patients with ascites caused by hypoproteinemia, leukopenia and/or throm-bocytopenia caused by hypersplenism, the first issue is control the tumor rather than adjuvant therapy.

关键词

肝肿瘤/肝功能不全/放射摄影术,介入性/化学疗法,肿瘤,局部灌注

Key words

Liver neoplasms/Hepatic insufficiency/Radiography/interventional/Chemotherapy/cancer/regional perfusion

分类

医药卫生

引用本文复制引用

夏景林..肝癌伴肝功能不全患者的介入治疗:策略与哲学思想[J].临床误诊误治,2018,31(1):1-5,5.

基金项目

上海市新百人项目(XBR2011002) (XBR2011002)

上海市优秀学科带头人项目(14XD1401100) (14XD1401100)

国家自然科学基金面上项目(81272732) (81272732)

临床误诊误治

OACSTPCD

1002-3429

访问量0
|
下载量0
段落导航相关论文